Dr Reddys Laboratories Key Financial Ratios, Dr Reddys …

Dr Reddys Labs Consolidated June 2024 Net Sales at Rs 7,696.10 crore, up 13.88% Y-o-Y. Dr Reddys Labs Standalone June 2024 Net Sales at Rs 5,841.20 crore, up 7.43% Y-o-Y. Dr Reddys Labs Standalone ...

CouponFollow Extension

88%
OFF

Dr Reddys Laboratories Key Financial Ratios, Dr Reddys …

1 week from now

moneycontrol.com

88%
OFF

Dr Reddys Laboratories Key Financial Ratios, Dr Reddys …

1 week from now

Reduce Dr Reddy’s Laboratories; target of Rs 6,350: ICICI Securities 29.07.2024 Dr Reddys Labs Consolidated June 2024 Net Sales at Rs 7,696.10 crore, up 13.88% Y-o-Y

moneycontrol.com

43%
OFF

Dr. Reddy's Laboratories Ratios And Metrics - Stock Analysis

1 week from now

Mar 31, 2020 · 0.43%. 0.91%. Upgrade. Source: S&P Capital IQ. Standard template. Financial Sources. Financial ratios and metrics for Dr. Reddy's Laboratories (RDY). Includes annual, …

stockanalysis.com

8%
OFF

Dr Reddys Laboratories Key Metrics: Find Key Metrics, Dr Reddys

1 week from now

Nov 8, 2024 · Dr Reddy's Laboratories Q1 Results: Net profit drops 0.8% to ₹1,392 crore, revenue rises 14% YoY; stock split declared 3 min read . 11:20 PM IST New businesses and …

livemint.com

5%
OFF

Dr Reddy's Clocks Highest-ever Revenue In Q2; Net Profit Down 9.5%

1 week from now

Nov 5, 2024 · Hyderabad-based Dr Reddy's Laboratories (DRL) posted a 9.5 per cent year-on-year (Y-o-Y) decline in its consolidated profit after tax (PAT) for Q2 FY25 at Rs 1,341.9 crore, …

business-standard.com

17%
OFF

Dr Reddy's Laboratories Ltd (RDY) (HY 2025) Earnings Call …

1 week from now

Nov 6, 2024 · Dr Reddy's Laboratories Ltd (NYSE:RDY) reported a strong performance with a 17% year-over-year revenue growth, reaching USD 957 million. The company achieved its …

yahoo.com

$14.61
OFF

Dr. Reddy's SWOT Analysis: Generic Drug Maker's Stock Shows …

1 week from now

5 days ago · As of November 5, 2024, Dr. Reddy's stock price stood at $14.61, with a market capitalization of $12.19 billion. This valuation reflects investor confidence in the company's …

investing.com

50%
OFF

Dr Reddys Laboratories Yearly Financial Results - CNBCTV18

1 week from now

Dr Reddys Laboratories. Share Price Live Chart Today. 1226.35 -18.65 (-1.50%) Prev. Close 1,245. Open Price 1,249. Volume 13,21,274. Mkt. Cap (₹ Cr.) 1,02,324. Balance Sheet Profit …

cnbctv18.com

45%
OFF

Dr Reddys Laboratories Consolidated Key Financial Ratios, Dr …

1 week from now

Hold Dr Reddy’s Laboratories; target of Rs 1270: ICICI Securities 06.11.2024 Dr Reddys Labs Consolidated September 2024 Net Sales at Rs 8,038.20 crore, up 16.45% Y-o-Y

moneycontrol.com

FAQs about Dr Reddys Laboratories Key Financial Ratios, Dr Reddys … Coupon?

What is the fiscal year of Dr Reddy's Laboratories (RDY)?

Fiscal year is Apr - Mar. Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC). Financial ratios and metrics for Dr. Reddy's Laboratories (RDY). Includes annual, quarterly and trailing numbers with full history and charts. ...

What does Dr Reddys labs do?

Dr Reddys Labs consolidated Financial Ratio, profitability ratios, company liquidity ratio, key financial analysis, statutory liquidity ratio, consolidated account statement on Moneycontrol. ...

What is Dr Reddy's Laboratories (RDY) price-to-earnings ratio?

Dr. Reddy's Laboratories (NYSE:RDY) has a trailing price-to-earnings ratio of 20.28 and a forward price-to-earnings ratio of 19.89. The price/earnings-to-growth ratio is 1.84. ...

How much does Dr Reddy's Laboratories (DRL) earn per share?

Dr. Reddy's Laboratories has generated $4.03 earnings per share over the last year ($4.03 diluted earnings per share) and currently has a price-to-earnings ratio of 20.3. Earnings for Dr. Reddy's Laboratories are expected to grow by 0.49% in the coming year, from $4.11 to $4.13 per share. Dr. ...

What is the net sales of Dr Reddys in India?

Dr Reddys Labs consolidated net sales in India were at Rs 5,474.90 crore in March 2022, up 14.82% Year-on-Year. Dr Reddys Labs standalone net sales in India were at Rs 3,668.70 crore in March 2022, up 9.49% Year-on-Year. ...